Approved by the us Food and Drug Administration in 1983 for epileptic seizures, VPA is also used as a mood stabilizer in various neuropsychiatric conditions, including dementia-related agitation.
This stimulation increases brain activity and releases neurotransmitters that are known to elevate mood, without the systemic side effects of drug treatments.